Pantoprazol Axicur Axicorp Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Axicur, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Axicur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Axicur is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and reduces further damage caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

Pantoprazol Axicur may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation: occasional. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: persistent diarrhoea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Fracture risk with long‑term use: especially hip, wrist or spine fractures. - Liver enzyme elevation: jaundice or abnormal blood tests. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy with Pantoprazol Axicur, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate need for long‑term therapy: weigh benefits against risks such as bone fracture. - Monitor magnesium levels: especially in patients on diuretics or prolonged treatment. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Axicur can affect the pharmacokinetics of several co‑administered drugs. Monitoring and dose adjustments may be necessary.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): markedly reduced absorption. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced antiplatelet effect. - Warfarin: potential alteration of INR. - Digoxin: increased serum levels. - Methotrexate (high dose): decreased renal clearance. - Oral contraceptives: possible reduction in efficacy.